Upregulation of microRNA-335 and microRNA-584 contributes to the pathogenesis of severe preeclampsia through downregulation of endothelial nitric oxide synthase

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 5383-5390

  Jiang, Feng ^a   Li, Jipeng ^b   Wu, Guojun ^c   Miao, Zhuo ^a   Lu, Linshan ^a   Ren, Guoping ^a   Wang, Xiaohong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Gastrointestinal Surgery ^*  (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial nitric oxide synthase; MicroRNA 335; microRNA 584; Preeclampsia; Trophoblast cell

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; LUCIFERASE; MICRORNA; MICRORNA 335; MICRORNA 584; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN335 MICRORNA, HUMAN; MIRN584 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; EX VIVO STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; PATHOGENESIS; PREECLAMPSIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA ANALYSIS; TISSUE LEVEL; TROPHOBLAST; UPREGULATION; BLOOD PRESSURE; CASE CONTROL STUDY; CELL LINE; CELL MOTION; CELL SURVIVAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PRE-ECLAMPSIA; PREGNANCY; RISK FACTOR; RNA INTERFERENCE; YOUNG ADULT;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NITRIC OXIDE SYNTHASE TYPE III; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; RNA INTERFERENCE; RNA, MESSENGER; TROPHOBLASTS; YOUNG ADULT;

EID: 84940570312     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4018     Document Type: Article

References (41)

1. Sibai B, Dekker G and Kupferminc M: Pre-eclampsia. Lancet 365: 785-799, 2005
2. Redman CW and Sargent IL: Latest advances in understanding preeclampsia. Science 308: 1592-1594, 2005
3. Grill S, Rusterholz C, Zanetti-Dallenbach R, Tercanli S, Holzgreve W, Hahn S and Lapaire O: Potential markers of preeclampsia-a review. Reprod Biol Endocrinol 7: 70, 2009.
4. Huppertz B: Placental origins of preeclampsia: Challenging the current hypothesis. Hypertension 51: 970-975, 2008.
5. Oudejans CB and van Dijk M: Placental gene expression and pre-eclampsia. Placenta 29 (Suppl A): S78-S82, 2008.
6. Sitras V, Paulssen RH, Grønaas H, Leirvik J, Hanssen TA, Vårtun A and Acharya G: Differential placental gene expression in severe preeclampsia. Placenta 30: 424-433, 2009.
7. Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA and Conrad KP: Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 30: 15-24, 2009
8. Enquobahrie DA, Meller M, Rice K, Psaty BM, Siscovick DS and Williams MA: Differential placental gene expression in preeclampsia. Am J Obstet Gynecol 199: 566 e561-e511, 2008.
9. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often fanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
10. Yu J, Wang F, Yang GH, Wang FL, Ma YN, Du ZW and Zhang JW: Human microRNA clusters: Genomic organization and expression profile in leukemia cell lines. Biochem Bioph Res Commun 349: 59-68, 2006.
11. Brennecke J, Hipfner DR, Stark A, Russell RB and Cohen SM: bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36, 2003.
12. Calame K: MicroRNA-155 function in B Cells. Immunity 27825-827, 2007
13. Jopling CL, Yi M, Lancaster AM, Lemon SM and Sarnow P: Modulation of hepatitis C virus RNA abundance by a liver-specifc MicroRNA. Science 309: 1577-1581, 2005
14. Hu Y, Li P, Hao S, Liu L, Zhao J and Hou Y Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med 47: 923-929, 2009
15. Mouillet JF, Chu T, Nelson DM, Mishima T and Sadovsky Y MiR-205 silences MED1 in hypoxic primary human tropho-blasts. FASEB J 24: 2030-2039, 2010.
16. Skrzypek K, Tertil M, Golda S, Ciesla M, Weglarczyk K, Collet G, Guichard A, Kozakowska M, Boczkowski J, Was H, et al: Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization and metastasis. Antioxid Redox Signal 19: 644-660, 2013.
17. Chen LT, Xu SD, Xu H, Zhang JF, Ning JF and Wang SF: MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis. Med Oncol 29: 1673-1680, 2012.
18. Corthorn J, Germain AA, Chacón C, Rey S, Soto GX, Figueroa CD, Müller-Esterl W, Duarte I and Valdés G: Expression of kallikrein, bradykinin b2 receptor and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia and placenta accreta. Endocrine 29: 491-499, 2006.
19. Li F, Hagaman JR, Kim HS, Maeda N, Jennette JC, Faber JE, Karumanchi SA, Smithies O and Takahashi N: eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype. J Am Soc Nephrol 23: 652-660, 2012.
20. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
21. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW and Lo YM: Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54: 482-490, 2008.
22. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, et al: Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148, 2008.
23. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE and Galas DJ: Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106: 4402-4407, 2009.
24. Sibai B, Dekker G and Kupferminc M: Pre-eclampsia. Lancet 365: 785-799, 2005
25. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, et al; CPEP Study Group: Soluble endoglin and other circulating antian-giogenic factors in preeclampsia. N Engl J Med 355: 992-1005, 2006.
26. Myatt L: Role of placenta in preeclampsia. Endocrine 19: 103-111, 2002.
27. Maynard S, Epstein FH and Karumanchi SA: Preeclampsia and angiogenic imbalance. Annu Rev Med 59: 61-78, 2008.
28. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM, Draghici S, Espinoza J, Kusanovic JP, Mittal P, et al: Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 196: 261 e261-e266, 2007
29. Roman H, Marpeau L and Hulsey TC: Surgeons' experience and interaction effect in randomized controlled trials regarding new surgical procedures. Am J Obstet Gynecol 199: 108 e101-e106, 2008.
30. Hu Y, Li P, Hao S, Liu L, Zhao J and Hou Y: Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med 47: 923-929, 2009
31. Guo G, Lade JA, Wilton AN, Moses EK, Grehan M, Fu Y, Qiu H, Cooper DW and Brennecke SP: Genetic susceptibility to pre-eclampsia and chromosome 7q36. Hum Genet 105: 641-647, 1999
32. Demircubuk AG, Coskun MY, Demiryurek S, Dokuyucu R, Öztuzcu S, Taviloglu ZS, Arslan A and Sivasli E Endothelial NOS gene Glu298Asp polymorphism in preterm neonates with respiratory distress syndrome. Pediatr Pulmonol 48: 976-980, 2013.
33. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, et al: Insulin resistance, hyperlipidemia and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104: 342-345, 2001.
34. Xiang W, Chen H, Hu L and Xu X: Endothelial nitric oxide synthase traffc inducer in the umbilical vessels of the patients with pre-eclampsia. J Huazhong U Sci Technolog Med Sci 29: 243-245, 2009
35. Soundararajan R and Rao AJ: Trophoblast 'pseudo-tumorigenesis': Signifcance and contributory factors. Reprod Biol Endocrinol 2: 15, 2004
36. Lala PK and Chakraborty C: Factors regulating trophoblast migration and invasiveness: Possible derangements contributing to pre-eclampsia and fetal injury. Placenta 24: 575-587, 2003.
37. Buhimschi I, Yallampalli C, Chwalisz K and Garfield RE: Pre-eclampsia-like conditions produced by nitric oxide inhibition: Effects of L-arginine, D-arginine and steroid hormones. Hum Reprod 10: 2723-2730, 1995
38. Enquobahrie DA, Abetew DF, Sorensen TK, Willoughby D, Chidambaram K and Williams MA: Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 204: 178 e112-e121, 2011.
39. Wang H, Li M, Zhang R, Wang Y, Zang W, Ma Y, Zhao G and Zhang G: Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299 Tumour Biol 343101-3109, 2013.
40. Ueno K, Hirata H, Shahryari V, Chen Y, Zaman MS, Singh K, Tabatabai ZL, Hinoda Y and Dahiya R: Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer 104: 308-315, 2011.
41. Caterina MJ and Devreotes PN: Molecular insights into eukaryotic chemotaxis. FASEB J 5: 3078-3085, 1991.